PTGS2 and early-onset autosomal dominant Alzheimer disease: It was also found that miR-103 promotes neurite outgrowth and reduces cell apoptosis by targeting prostaglandin-endoperoxide synthase 2 (PTGS2) in cellular models of Alzheimer’s disease [40].